---
title: Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD),
  type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence
date: '2022-11-28'
linkTitle: http://rd.springer.com/10.1007/s11306-022-01960-1
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">Accumulating
  evidence have shown a significant correlation between urinary volatile organic compounds
  (VOCs) profile and the manifestation of several physiological and pathological states,
  including liver diseases. Previous studies have investigated the urinary metabolic
  signature as a non-invasive tool for the early discrimination between non-alcoholic
  fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), which nowadays ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">Accumulating evidence have shown a significant correlation between urinary volatile organic compounds (VOCs) profile and the manifestation of several physiological and pathological states, including liver diseases. Previous studies have investigated the urinary metabolic signature as a non-invasive tool for the early discrimination between non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), which nowadays ...